Teva Uses Grassroot Efforts to Retain Copaxone Customers; Insurers Remain Unconvinced

In the race to switch multiple sclerosis patients to a new, patent-protected version of its top selling drug, Copazone, Teva Pharmaceutical Industries is using records from its 24-hour support hotline in the U.S. to personally contact 85,000 patients.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news